English
This article is from Vaccine , volume 32 . Abstract •We explored Cervarix® HPV vaccine cross-reactive antibody specificity.•L1 VLP binding was a poor surrogate for L1L2 pseudovirus neutralization specificity.•Cross-neutralizing antibodies comprise a small proportion of total antibody.•Multiple, overlapping cross-neutralizing antibody specificities exist.
Sign in with your free account to read, download EPUBs or listen.
Ebook · Cross-neutralizing antibodies elicited by the Cervarix® human papillomavirus vaccine display a range of Alpha-9 inter-type specificities☆. · Bissett, Sara L., Draper, Eve, Myers, Richard E., Godi, Anna, Beddows, Simon · Internet Archive